A Randomized, Controlled, Multicentre, Phase IIb Safety and Efficacy Study of HGT-1410 (Recombinant Human Heparan N Sulfatase) Administration via an Intrathecal Drug Delivery Device in Pediatric Patients
|Effective start/end date||12/15/14 → 10/31/16|
- SHIRE HUMAN GENETIC THERAPIES, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.